ONWARD Medical H1 FY26 operating loss widens to EUR 23.3 million; revenue climbs 240% to EUR 4.2 million
Reuters2026/09/09 05:30- ONWARD Medical posted H1 2026 revenue of EUR 4.2 million, up from EUR 1.2 million a year earlier.
- ARC-EX revenue more than doubled to EUR 3.4 million, driven by 159 systems sold or supplied via paid evaluation, up 430% year over year.
- Operating loss widened to EUR 23.3 million; net loss deepened to EUR 24.7 million.
- Cash rose to EUR 81.5 million after raising EUR 40.6 million in equity; it also secured up to EUR 50 million from BlackRock.
- Empower BP enrolled 22 participants with 14 active sites; CEO Dave Marver cited strong ARC-EX traction and pipeline progress.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Storage Giant Offers Huge Bonuses Again: Micron Awards Up to 68 Months’ Bonus
Micron Technology has announced record-breaking bonuses for its employees in Taiwan, ranging from 35 to 68 months’ salary, with a minimum cash compensation of 1.7 million New Taiwan dollars. However, the Taoyuan union, representing about two-thirds of Micron’s workers in Taiwan, has refused to accept the offer, insisting that 15% of operating profits be included in the bonus distribution and maintaining the threat of a strike.
Dogecoin ETF Closure Sets October Exit for Bitwise BWOW Holders
Crypto prices
More
